ALLOPURINOL-INDUCED OROTIDINURIA - A TEST FOR MUTATIONS AT THE ORNITHINE CARBAMOYLTRANSFERASE LOCUS IN WOMEN

被引:105
作者
HAUSER, ER
FINKELSTEIN, JE
VALLE, D
BRUSILOW, SW
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205
关键词
D O I
10.1056/NEJM199006073222305
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ornithine carbamoyltransferase is an X-linked mitochondrial enzyme expressed in hepatocytes and enterocytes. A deficiency of this enzyme results in central nervous system dysfunction, which may be fatal in newborn boys. Milder forms are seen in older boys and girls and in adults. Establishing the carrier status of women at risk for ornithine carbamoyltransferase deficiency is important for determining reproductive and medical risks for affected women. We report a test to establish the carrier status of women at risk for ornithine carbamoyltransferase deficiency. This test relies on the allopurinol-induced accumulation of orotidine, whose synthesis is stimulated by carbamoyl phosphate, a substrate that accumulates in ornithine carbamoyltransferase deficiency. We used anion-exchange, high-performance liquid chromatography to measure urinary orotidine and orotic acid excretion after the administration of a 300-mg oral dose of allopurinol in 24 women who were obligate heterozygotes, 13 who were probable heterozygotes, 15 mothers of affected boys from monoplex families (families with only one affected member), 12 mothers of affected girls from monoplex families, and 25 normal, unrelated women who were not carriers. Urinary orotidine excretion was increased 3 SD or more above the mean value for the normal women in 95.8 percent of the obligate heterozygotes, 84.6 percent of the probable heterozygotes, 73.3 percent of the mothers of affected boys in monoplex families, and 33.3 percent of the mothers of affected girls in monoplex families, thus establishing that these women were carriers of a mutant ornithine carbamoyltransferase allele. The presence of allopurinol-induced orotic aciduria was not as sensitive or specific an indicator of carrier status as the presence of orotidinuria. We conclude that measurement of urinary orotidine excretion after the administration of allopurinol is a simple and reliable test for the identification of women who are heterozygous for ornithine carbamoyltransferase deficiency. (N Engl J Med 1990; 322:1641–5). © 1990, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:1641 / 1645
页数:5
相关论文
共 31 条
  • [1] ADACHI TORU, 1963, J VITAMINOL, V9, P217
  • [2] HYPERAMMONEMIA IN WOMEN WITH A MUTATION AT THE ORNITHINE CARBAMOYLTRANSFERASE LOCUS - A CAUSE OF POSTPARTUM COMA
    ARN, PH
    HAUSER, ER
    THOMAS, GH
    HERMAN, G
    HESS, D
    BRUSILOW, SW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (23) : 1652 - 1655
  • [3] GERMLINE MOSAICISM AND DUCHENNE MUSCULAR-DYSTROPHY MUTATIONS
    BAKKER, E
    VAN BROECKHOVEN, C
    BONTEN, EJ
    VANDEVOOREN, MJ
    VEENEMA, H
    VANHUL, W
    VANOMMEN, GJB
    VANDENBERGHE, A
    PEARSON, PL
    [J]. NATURE, 1987, 329 (6139) : 554 - 556
  • [4] FALSE POSITIVE ALANINE TOLERANCE-TEST RESULTS IN HETEROZYGOTE DETECTION OF UREA CYCLE DISORDERS
    BATSHAW, ML
    NAYLOR, EW
    THOMAS, GH
    [J]. JOURNAL OF PEDIATRICS, 1989, 115 (04) : 595 - 598
  • [5] BEARDMORE TD, 1971, J LAB CLIN MED, V78, P696
  • [6] Brusilow S.W., 1989, METABOLIC BASIS INHE, P629
  • [7] BRUSILOW SW, 1985, GENETIC METABOLIC DI, V5, P140
  • [8] BRUSILOW SW, IN PRESS TECHNIQUES
  • [9] DRISCOLL D J, 1989, American Journal of Human Genetics, V45, pA111
  • [10] FINKELSTEIN JE, IN PRESS GENOMICS